{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:12:37Z","timestamp":1791357157159,"version":"4.3.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1017\/s1461145711001076","type":"journal-article","created":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T10:37:19Z","timestamp":1311331039000},"page":"107-118","source":"Crossref","is-referenced-by-count":71,"title":["A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia"],"prefix":"10.1093","volume":"15","author":[{"given":"W. Wolfgang","family":"Fleischhacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srihari","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Gassmann-Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Remmerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Eerdekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,2]]},"reference":[{"key":"key\n\t\t\t\t20170713084219_ref001","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"key\n\t\t\t\t20170713084219_ref002","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1742-1241.2009.02240.x","article-title":"Paliperidone palmitate \u2013 review of the efficacy, safety, and cost of a new second generation depot antipsychotic medication","volume":"64","author":"Citrome","year":"2010","journal-title":"International Journal of Clinical Practice"},{"key":"key\n\t\t\t\t20170713084219_ref004","volume-title":"Long-term safety, tolerability and pharmacokinetics of paliperidone palmitate: a one-year open-label study in patients with schizophrenia","author":"Coppola","year":"2009"},{"key":"key\n\t\t\t\t20170713084219_ref005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1192\/bjp.195.52.s29","article-title":"Second-generation antipsychotic long-acting injections: systematic review","volume":"195","author":"Fleischhacker","year":"2009","journal-title":"British Journal of Psychiatry"},{"key":"key\n\t\t\t\t20170713084219_ref006","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.pnpbp.2009.11.022","article-title":"Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics","volume":"34","author":"Fujii","year":"2009","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"key\n\t\t\t\t20170713084219_ref007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/YIC.0b013e32833948fa","article-title":"Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study","volume":"25","author":"Gopal","year":"2010","journal-title":"International Clinical Psychopharmacology"},{"key":"key\n\t\t\t\t20170713084219_ref008","article-title":"AIMS","volume-title":"Abnormal Involuntary Movement Scale, Early Clinical Drug Evaluation Unit (ECDEU), Assessment Manual for Psychopharmacology","author":"Guy","year":"1976","edition":"revised edn."},{"key":"key\n\t\t\t\t20170713084219_ref009","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.pnpbp.2009.05.014","article-title":"Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia","volume":"33","author":"Hough","year":"2009","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"key\n\t\t\t\t20170713084219_ref09a","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1176\/appi.ajp.160.6.1125","article-title":"Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic","volume":"160","author":"Kane","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"key\n\t\t\t\t20170713084219_ref010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02245603","article-title":"5-HT2 antagonism and EPS benefits: is there a casual connection?","volume":"457","author":"Kapur","year":"1996","journal-title":"Psychopharmacology"},{"key":"key\n\t\t\t\t20170713084219_ref011","first-page":"85","article-title":"Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects","volume":"81","author":"Karlsson","year":"2006","journal-title":"Schizophrenia Research"},{"key":"key\n\t\t\t\t20170713084219_ref012","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/00926230600666378","article-title":"A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning","volume":"32","author":"Knegtering","year":"2006","journal-title":"Journal of Sex and Marital Therapy"},{"key":"key\n\t\t\t\t20170713084219_ref013","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1176\/appi.ajp.162.5.1010","article-title":"Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels","volume":"162","author":"Knegtering","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"key\n\t\t\t\t20170713084219_ref014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.jcp.0000106220.36344.04","article-title":"A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning","volume":"24","author":"Knegtering","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"key\n\t\t\t\t20170713084219_ref015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psyneuen.2008.08.015","article-title":"Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia","volume":"34","author":"Konarzewska","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"key\n\t\t\t\t20170713084219_ref016","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S1461145709990988","article-title":"Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study","volume":"13","author":"Kramer","year":"2009","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20170713084219_ref017","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"key\n\t\t\t\t20170713084219_ref018","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2007-992140","article-title":"Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia","volume":"40","author":"Marinis","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"key\n\t\t\t\t20170713084219_ref019","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hup.811","article-title":"Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite","volume":"21","author":"Melkersson","year":"2006","journal-title":"Human Psychopharmacology"},{"key":"key\n\t\t\t\t20170713084219_ref020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/0019-5545.58291","article-title":"A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine","volume":"51","author":"Nagaraj","year":"2009","journal-title":"Indian Journal of Psychiatry"},{"key":"key\n\t\t\t\t20170713084219_ref021","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/npp.2010.79","article-title":"A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic in schizophrenia","volume":"35","author":"Nasrallah","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t20170713084219_ref022","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/ajp.152.2.173","article-title":"D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate","volume":"152","author":"Nyberg","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"key\n\t\t\t\t20170713084219_ref023","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/JCP.0b013e3181dd3103","article-title":"A randomized, placebo-controlled study to assess the efficacy and safety of three doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia","volume":"30","author":"Pandina","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"key\n\t\t\t\t20170713084219_ref024","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pnpbp.2010.11.008","article-title":"A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia","volume":"35","author":"Pandina","year":"2010","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"key\n\t\t\t\t20170713084219_ref025","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/NDT.S3311","article-title":"Risperidone long-acting injection: a review of its long term safety and efficacy","volume":"4","author":"Rainer","year":"2008","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"key\n\t\t\t\t20170713084219_ref026","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11316870-000000000-00000","article-title":"Population pharmacokinetics of intramuscular paliperidone palmitate in patients with schizophrenia: a novel once-monthly, long-acting formulation of an atypical antipsychotic","volume":"48","author":"Samtani","year":"2009","journal-title":"Clinical Pharmacokinetics"},{"key":"key\n\t\t\t\t20170713084219_ref027","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"key\n\t\t\t\t20170713084219_ref028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/CVM-1-1-019","article-title":"Noninferiority trials","volume":"1","author":"Snapinn","year":"2000","journal-title":"Current Controlled Trials in Cardiovascular Medicine"},{"key":"key\n\t\t\t\t20170713084219_ref029","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/14740338.6.6.651","article-title":"The pharmacology and safety of paliperidone extended-release in the treatment of schizophrenia","volume":"6","author":"Spina","year":"2007","journal-title":"Expert Opinion on Drug Safety"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/15\/1\/107\/18561309\/15-1-107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T16:57:37Z","timestamp":1503507457000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article-lookup\/doi\/10.1017\/S1461145711001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,2]]},"published-print":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1017\/s1461145711001076","relation":{},"ISSN":["1469-5111","1461-1457"],"issn-type":[{"value":"1469-5111","type":"electronic"},{"value":"1461-1457","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}